Investigation of Acorda Therapeutics, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder Claim – Yahoo Finance

DALLAS, June 5, 2012 /PRNewswire/ -- Goldfarb LLP is investigating whether the board of directors of Acorda Therapeutics, Inc. (ACOR) violated shareholder protection laws by allegedly breaching compliance matters concerning adverse drug ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>